Cepheid congratulates Executive Vice President, Chief Medical and Scientific Officer, David H. Persing, MD, Ph.D., for receiving the 2024 California Life Sciences (CLS) Pantheon Leadership award. The ...

Ellucian, the leading higher education technology solutions provider, today announced that the University of East London (UEL) will implement Banner, part of the Ellucian SaaS Platform. A new Ellucian ...

As CVS Health expands into different roles across the healthcare journey, the company earns access to more — and more accurate and up-to-date — patient information. With their enlarged scope ...

Streamlining data processing and analysis Two of the biggest factors shaping this sector are the availability of new sources of health information ... will reduce manual work and streamline ...

When they are damaged, they may cause pain, or if severely affected, they may stop relaying information to and from the brain ... According to the Merck Veterinary Manual, nerves regenerate at a rate ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

The company is paying China-based biotech LaNova Medicines $588 million for the same type of bispecific antibody drug that ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...

The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...

The life-sciences and chemical group said it now expects 2024 net sales in the lower half of its previously expected range of ...